Hydroxyethylstarch sedimentation by gravity ex vivo for red cell reduction of granulocyte apheresis components

Journal of Clinical Apheresis

Volumn 13, Issue 2, 1998, Pages 56-61

  Adkins, D ^b   Johnston, M ^a   Walsh, J ^a   Spitzer, G ^a   Goodnough, T ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Granulocyte transfusions; Hetastarch sedimentation; Red blood cells

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; HETASTARCH;

ARTICLE; BONE MARROW TRANSPLANTATION; DONOR; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE SEDIMENTATION RATE; GRANULOCYTE; HUMAN; HUMAN EXPERIMENT; LEUKAPHERESIS; NORMAL HUMAN; SIBLING; SUBCUTANEOUS DRUG ADMINISTRATION;

ERYTHROCYTES; GRANULOCYTES; GRAVITATION; HETASTARCH; HUMANS; LEUKAPHERESIS; LEUKOCYTE TRANSFUSION;

EID: 0031827984     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1101(1998)13:2<56::AID-JCA2>3.0.CO;2-7     Document Type: Article

References (59)

1. Momin F, Chandrasekar PH: Antimicrobial prophylaxis in bone marrow transplantation. Ann Intern Med 123:205-215, 1995.
2. Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G: Filgrastim (r-metHuG-CSF): The first 10 years. Blood 88:1907-1929, 1996.
3. DePauw BE, Deresinski SC, Feld R, et al: Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. Ann Intern Med 120:834-844, 1994.
4. Appelbaum FR, Bowles CA, Makuch, RW, Deisseroth AB: Granulocyte transfusion therapy of experimental Pseudomonas septicemia: Study of cell dose and collection technique. Blood 52:323-331, 1978.
5. Debelak KM, Epstein RB, Andersen BR: Granulocyte transfusions in leukopenic dogs: In vivo and in vitro function of granulocytes obtained by continuous-flow filtration leukapheresis. Blood 43:757-766, 1974.
6. Epstein RB, Waxman FJ, Bennett BT, Andersen BR: Pseudomonas septicemia in neutropenic dogs. Treatment with granulocyte transfusions. Transfusion 14:51-57, 1974.
7. Epstein RB, Clift RA, Thomas ED: The effect of leukocyte transfusions on experimental bacteremia in the dog. Blood 34:782-790, 1969.
8. Westrick MA, Debelak-Fehir KM, Epstein RB: The effect of prior whole blood transfusion on subsequent granulocyte support in leukopenic dogs. Transfusion 17:611-620, 1977.
9. Dale DC, Reynolds HY, Pennington JE, et al: Granulocyte transfusion therapy of experimental Pseudomonas pneumonia. J Clin Invest 54:664-671, 1974.
10. Dale DC, Reynolds HY, Pennington JE, et al: Experimental Pseudomonas pneumonia in leukopenic dogs: Comparison of therapy with antibiotics and granulocyte transfusions. Blood 47:869-876, 1976.
11. Chow HS, Sarpel SC, Epstein RB: Pathophysiology of Candida albicans meningitis in normal, neutropenic, and granulocyte transfused dogs. Blood 55:546-551, 1980.
12. Chow HS, Sarpel SC, Epstein RB: Experimental candidiasis in neutropenic dogs: Tissue burden of infection and granulocyte transfusion effects. Blood 59:328-333, 1982.
13. Epstein RB, Chow HS: An analysis of quantitative relationships of granulocyte transfusion therapy in canines. Transfusion 21:360-332, 1981.
14. Clift RA, Sanders JE, Thomas ED, et al: Granulocyte transfusions for the prevention of infection in patients receiving bone marrow transplants. N Engl J Med 298:1052-1057, 1978.
15. Winston DJ, Ho WG, Young LS, Gale RP: Prophylactic granulocyte transfusions during human bone marrow transplantation. Am J Med 68:893-897, 1980.
16. Schiffer CA, Aisner J, Daly PA, et al: Alloimmunization following prophylactic granulocyte transfusion. Blood 54:766-774, 1979.
17. Mannoni P, Rodet M, Vernant JP, et al: Efficiency of prophylactic granulocyte transfusions in preventing infections in acute leukemia. Blood Transf Immunohematol 22:503-518, 1979.
18. Strauss RG, Connett JE, Gale RP, et al: A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med 305: 597-603, 1981.
19. Sutton DMC, Shumak KH, Baker MA: Prophylactic granulocyte transfusions in acute leukemia. Plasma Ther Transfus Technol 3:45-50, 1982.
20. Ford JM, Cullen MH, Roberts MM, et al: Prophylactic granulocyte transfusions: Results of a randomized controlled trial in patients with acute myelogenous leukemia. Transfusion 22:311-316, 1982.
21. Gomez-Villagran JL, Torres-Gomez A, Gomez-Garcia P, et al: A controlled trial of prophylactic granulocyte transfusions during induction chemotherapy for acute nonlymphoblastic leukemia. Cancer 54:734-738, 1984.
22. Higby DJ, Yates JW, Henderson ES, Holland JF: Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med 292:761-766, 1975.
23. Graw RG Jr, Herzig G, Perry S, Henderson ES: Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med 287:367-371, 1972.
24. Herzig RH, Herzig GP, Graw RG Jr, et al: Successful granulocyte transfusion therapy for gram negative septicemia. A prospectively randomized controlled study. N Engl J Med 296:701-705, 1977.
25. Vogler WR, Winton EF: A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 63:548-555, 1977.
26. Alavi JB, Root RK, Djerassi I, et al: A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 296:706-711, 1977.
27. Fortuny IE, Bloomfield CD, Hadlock DC, et al: Granulocyte transfusion: A controlled study in patients with acute non-lymphocytic leukemia. Transfusion 15:548-558, 1975.
28. Winston DJ, Ho WG, Gale RP: Therapeutic granulocyte transfusions for documented infections. A controlled trial in ninety-five infectious granulocytopenic episodes. Ann Int Med 97:509-515, 1982.
29. Laurenti F, Ferro R, Isacchi G, et al: Polymorphonuclear leukocyte transfusion for the treatment of sepsis in the newborn infant. J Pediatr 98:118-123, 1981.
30. Christensen RD, Rothstein G, Anstall HB, Bybee B: Granulocyte transfusions in neonates with bacterial infection, neutropenia, and depletion of mature marrow neutrophils. Pediatrics 70:1-6, 1982.
31. Cairo MS, Worcester C, Rucker R, et al: Role of circulating complement and polymorphonuclear leukocyte transfusion in treatment and outcome in critically ill neonates with sepsis. J Pediatr 110:935-941, 1987.
32. Wheeler JG, Chauvenet AR, Johnson CA, et al: Buffy coat transfusions in neonates with sepsis and neutrophil storage pool depletion. Pediatrics 79:422-425, 1987.
33. Baley JE, Stork EK, Warkentin PI, Shurin SB: Buffy coat transfusions in neutropenic neonates. Pediatrics 80:712-720, 1987.
34. Vamvakas EC, Pineda AA: Determinants of the efficacy of prophylactic granulocyte transfusions: A meta-analysis. J Clin Apheresis 12:74-81, 1997.
35. Vamvakas EC, Pineda AA. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apheresis 11:1-9, 1996.
36. Strauss RG: Therapeutic granulocyte transfusions in 1993 (editorial). Blood 81:1675-1678, 1993.
37. Strauss RG. Clinical perspectives of granulocyte transfusions: Efficacy to date. J Clin Apheresis 10:114-118, 1995.
38. Graw RG Jr, Goldstein IM, Eyre HJ, Terasaki PI: Histocompatibility testing for leucocyte transfusion. Lancet 1:77-78, 1970.
39. Higby DJ, Mishler JM, Cohen E, et al: Increased elevation of peripheral leukocyte counts by infusion of histocompatible granulocytes. Vox Sang 27:186-189, 1974.
40. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA. Neutrophil kinetics in man. J Clin Invest 58:705-715, 1976.
41. Bensinger WI, Price TH, Dale DC, et al: The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 81:1883-1888, 1993.
42. Caspar CB, Seger RA, Burger J, Gmur J: Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 81:2866-2871, 1993.
43. Begley CG, Lopez AF, Nicola NA, et al: Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: A rapid and sensitive microassay for colony-stimulating factors. Blood 68:162-166, 1986.
44. Colotta F, Re F, Polentarutti N, et al: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012-2020, 1992.
45. Lues WC, Rodger ER, Dale DC: In vivo administration of granulocyte colony-stimulating factor (G-CSF) to normal human subjects: Priming of the respiratory burst and inhibition of apoptosis in neutrophils (abstract). Blood 84:24a, 1994.
46. Colotta F, Re F, Mantovani A: Granulocyte transfusions from granulocyte colony-stimulating factor treated donors: Also a question of cell survival? (letter). Blood 82:2258, 1993.
47. MacPherson JL, Nusbacher J, Bennett JM: The acquisition of granulocytes by leukapheresis: A comparison of continuous flow centrifugation and filtration leukapheresis in normal and corticosteroid-stimulated donors. Transfusion 16:221-228, 1976.
48. Shoji M, Vogler WR. Effects of hydrocortisone on the yield and bactericidal function of granulocytes collected by continuous flow centrifugation. Blood 44:435-443, 1974.
49. Adkins D, Spitzer G, Johnston M, et al: Transfusions of granulocyte-colony-stimulating factor mobilized granulocyte components to allogeneic transplant recipients: Analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts. Transfusion 37:737-748, 1997.
50. Adkins D, Goodgold H, Hendershott, et al: Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplant 19:809-812, 1997.
51. Hester JP, Dignani MC, Anaissie EJ, et al: Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apheresis 10:188-193, 1995.
52. Leitman SF, Oblitas JM, Emmons R, Dunn DE, Young NS: Clinical efficacy of daily G-CSF recruited granulocyte transfusions in patients with severe neutropenia and life-threatening infections. Blood 88:331a (abstract 1313), 1996.
53. Fleming R, Anaissie E, O'Brien S, et al: Treatment of neutropenia related fungal infections with G-CSF mobilized granulocyte transfusions. Blood 88:331a (abstract 1312), 1996.
54. Adkins D, Goodnough LT, Brown, R, et al: G-CSF mobilized granulocyte components transfused into autologous transplant recipients results in significant and sustained absolute neutrophil count (ANC) increments. Blood 90:126b (abstract 3278), 1997.
55. Brown RA, Adkins DR, Goodnough LT, et al: Infusion of granulocytes collected from HLA- identical sibling donors reduces the duration of neutropenia following allogeneic peripheral blood stem cell (PBSC) transplant. Blood 88:261b (abstract 3772), 1996.
56. American Association of Blood Banks: "Standards for Blood Banks and Transfusion Services," 17th ed. Bethesda, MD: American Association of Blood Banks, 1996.
57. Braine HG, Sensenbrenner LL, Wright SK, et al: Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion. Blood 60: 420-425, 1982.
58. Dinsmore RE, Reich LM, Kapoor N, et al: ABH incompatible bone marrow transplantation: Removal of erythrocytes by starch sedimentation. Br J Haematol 54:441-449, 1983.
59. Lee JH, Leitman SF, Klein HG. A controlled comparison of the efficacy of hetastarch and pentastarch in granulocyte collections by centrifugal leukapheresis. Blood 86:4662-4666, 1995.